In the BioHarmony Drug Report Database

"Preview" Icon

Golimumab

Simponi, Simponi Aria (golimumab) is an antibody pharmaceutical. Golimumab was first approved as Simponi on 2009-04-24. It is used to treat rheumatoid arthritis in the USA. It has been approved in Europe to treat ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. The pharmaceutical is active against tumor necrosis factor.

 

Trade Name

 

Simponi
 

Common Name

 

golimumab
 

ChEMBL ID

 

CHEMBL1201833
 

Indication

 

ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis
 

Drug Class

 

Monoclonal antibodies

Image (chem structure or protein)

Golimumab structure rendering